Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pilar Escribano

Showing results (231-240 of 270) with videos related to

Pageof 27
Sort By:
European Heart Journal|July 20, 2023
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular functionIrene M Lang, Arne K Andreassen, Asger Andersen, et al.
Diagnostics (Basel, Switzerland)|October 24, 2020
Feasibility of a Noninvasive Operability Assessment in Chronic Thromboembolic Pulmonary Hypertension under Real-World PracticeAdriana Rodriguez Chaverri, Yolanda Revilla Ostolaza, Maria Jesus Lopez-Gude, et al.
The European Respiratory Journal|August 30, 2022
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extensionMarc Humbert, Vallerie McLaughlin, J Simon R Gibbs, et al.
Medicina Clinica|October 14, 2018
Evaluation of a nurse-led intervention program in heart failure: A randomized trialCarlos Ortiz-Bautista, Laura Morán-Fernández, Marta Díaz-García, et al.
The New England Journal of Medicine|March 31, 2021
Sotatercept for the Treatment of Pulmonary Arterial HypertensionMarc Humbert, Vallerie McLaughlin, J Simon R Gibbs, et al.
Frontiers in Public Health|March 4, 2024
Assessing the clinical benefit, safety, and patient-reported outcomes with the use of the PAHcare™ digital platform in pulmonary arterial hypertension: a pilot studyGregorio Pérez Peñate, Nuria Ochoa Parra, Juan Antonio Domingo Morera, et al.
Frontiers in Public Health|December 26, 2022
Evaluation of a digital health system (PAHcare™) for routine care of patients with pulmonary arterial hypertension: The CBS-PAH study protocolGregorio Pérez Peñate, Nuria Ochoa Parra, Juan Antonio Domingo Morera, et al.
Plos One|April 30, 2020
Clinical heterogeneity of Pulmonary Arterial Hypertension associated with variants in TBX4Ignacio Hernandez-Gonzalez, Jair Tenorio, Julian Palomino-Doza, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2023
Trends in antifungal resistance in <i>Candida</i> from a multicenter study conducted in Madrid (CANDIMAD study): fluconazole-resistant <i>C. parapsilosis</i> spreading has gained traction in 2022Judith Díaz-García, Marina Machado, Luis Alcalá, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2025
Impact of Fluconazole Resistance on the Outcomes of Patients With Candida parapsilosis Bloodstream Infections: A Retrospective Multicenter StudyAntonio Vena, Giusy Tiseo, Marco Falcone, et al.
Pageof 27

Showing results (231-240 of 270) with videos related to

Sort By:
Pageof 27
European Heart Journal|July 20, 2023
Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a clinical consensus statement of the ESC working group on pulmonary circulation and right ventricular functionIrene M Lang, Arne K Andreassen, Asger Andersen, et al.
Diagnostics (Basel, Switzerland)|October 24, 2020
Feasibility of a Noninvasive Operability Assessment in Chronic Thromboembolic Pulmonary Hypertension under Real-World PracticeAdriana Rodriguez Chaverri, Yolanda Revilla Ostolaza, Maria Jesus Lopez-Gude, et al.
The European Respiratory Journal|August 30, 2022
Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extensionMarc Humbert, Vallerie McLaughlin, J Simon R Gibbs, et al.
Medicina Clinica|October 14, 2018
Evaluation of a nurse-led intervention program in heart failure: A randomized trialCarlos Ortiz-Bautista, Laura Morán-Fernández, Marta Díaz-García, et al.
The New England Journal of Medicine|March 31, 2021
Sotatercept for the Treatment of Pulmonary Arterial HypertensionMarc Humbert, Vallerie McLaughlin, J Simon R Gibbs, et al.
Frontiers in Public Health|March 4, 2024
Assessing the clinical benefit, safety, and patient-reported outcomes with the use of the PAHcare™ digital platform in pulmonary arterial hypertension: a pilot studyGregorio Pérez Peñate, Nuria Ochoa Parra, Juan Antonio Domingo Morera, et al.
Frontiers in Public Health|December 26, 2022
Evaluation of a digital health system (PAHcare™) for routine care of patients with pulmonary arterial hypertension: The CBS-PAH study protocolGregorio Pérez Peñate, Nuria Ochoa Parra, Juan Antonio Domingo Morera, et al.
Plos One|April 30, 2020
Clinical heterogeneity of Pulmonary Arterial Hypertension associated with variants in TBX4Ignacio Hernandez-Gonzalez, Jair Tenorio, Julian Palomino-Doza, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2023
Trends in antifungal resistance in <i>Candida</i> from a multicenter study conducted in Madrid (CANDIMAD study): fluconazole-resistant <i>C. parapsilosis</i> spreading has gained traction in 2022Judith Díaz-García, Marina Machado, Luis Alcalá, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2025
Impact of Fluconazole Resistance on the Outcomes of Patients With Candida parapsilosis Bloodstream Infections: A Retrospective Multicenter StudyAntonio Vena, Giusy Tiseo, Marco Falcone, et al.
Pageof 27